Jahresbericht 2006 - Caritas-Krankenhaus St. Josef Regensburg

9) Publikationen – Vorträge
Publikationen
Originalarbeiten
Family-based association study of the MTHFR polymorphism C677T in the bladderexstrophy-epispadias-complex.
Reutter H, Becker T, Ludwig M, Schäfer N, Detlefsen B, Beaudoin S, Fisch M, Ebert AK,
Rösch W, Nöthen MM, Boemers TM, Betz RC
Am J Med Genet A. 2006;140(22): 2506-9 (Impact Factor 2005: 1,913)
Gene expression of 5-, 12-, and 15-lipoxygenases and leukotriene receptors along the rat
nephron.
Reinhold SW, Vitzthum H, Filbeck T, Wolf K, Lattas C, Riegger GA, Kurtz A, Krämer BK
Am J Physiol Renal Physiol. 2006;290(4): F864-72 (Impact Factor 2005: 4,263)
Elevated microsatellite instability at selected tetranucleotide repeats does not correlate
with clinicopathologic features of bladder cancer.
Burger M, Burger SJ, Denzinger S, Wild PJ, Wieland WF, Blaszyk H, Obermann EC,
Stoehr R, Hartmann A
Eur Urol. 2006;50(4): 770-5; discussion 776 (Impact Factor 2005: 3,542)
Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated
by B-RAF mutations.
Burger M, Denzinger S, Hammerschmied C, Tannapfel A, Maderstorfer A, Wieland WF,
Hartmann A, Stoehr R
Eur Urol. 2006;50(5): 1102-9; discussion 1109-1 (Impact Factor 2005: 3,542)
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic
organ mapping, loss of heterozygosity, fluorescence in situ
hybridization, and p53 analyses.
Denzinger S, Mohren K, Knuechel R, Wild PJ, Burger M, Wieland WF, Hartmann A, Stoehr
R
Hum Pathol. 2006;37(2): 143-51 (Impact Factor 2005: 2,550)
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
Blank C, Kuball J, Voelkl S, Wiendl H, Becker B, Walter B, Majdic O, Gajewski TF,
Theobald M, Andreesen R, Mackensen A
Int J Cancer. 2006;119(2): 317-27 (Impact Factor 2005: 4,700)
Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial
hyperplasias of the bladder.
van Oers JM, Adam C, Denzinger S, Stoehr R, Bertz S, Zaak D, Stief C, Hofstaedter F,
Zwarthoff EC, van der Kwast TH, Knuechel R, Hartmann A
Int J Cancer. 2006;119(5): 1212-5 (Impact Factor 2005: 4,700)
Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing
transurethral resection of the prostate.
25